LeonaBio, Inc. (LONA) stock
LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.65−0.11 (-3.99%)
Close on Nov 18, 2026Market cap $24.97MP/E –Yield –
LeonaBio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
LeonaBio's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.93M. For fiscal 2025 it was -$45.73M. The highest annual figure on record is -$3.71M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$45.73M | – |
| FY2024 | Dec 31, 2024 | -$97.17M | – |
| FY2023 | Dec 31, 2023 | -$100.75M | – |
| FY2022 | Dec 31, 2022 | -$72.47M | – |
| FY2021 | Dec 31, 2021 | -$43.10M | – |
| FY2020 | Dec 31, 2020 | -$24.11M | – |
| FY2019 | Dec 31, 2019 | -$3.71M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.40M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.67M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$26.01M | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$26.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$26.19M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.67M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.59M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.57M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.18M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.30M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.32M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.67M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.41M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.18M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.03M | – |
See a number that looks wrong?